네이처셀
22,850KRWMarket close of 10/21 (Wed)
Down -1.51%-350KRWMarket close of 10/21 (Wed)
- Open
- 23,400
- High
- 23,950
- Low
- 22,600
- Day range
- Day range low 22,600 high 23,950, open 23,400, close 22,850, previous close 23,200
- Volume
- 16×10K shares
- 3.6B KRW 0.82× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
34%1-year close range 16,900 to 34,550 won, 34% up from the low
34% of the way up from the lowest close in 1 year (252 sessions) · -33.9% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-3.7B KRWOperating income over the last four quarters -3.7B KRW (loss)
- Daily moveusual range-1.51%-1.51%, 0.7× the usual (20-session average ±2.11%)That day -1.51% · usual ±2.11% · large-move threshold ±4.2%
- Trading valueusual range0.8×3.6B KRW, 0.8× the 20-session average0.82× the 20-session average · check threshold 3×
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional-300.00 million KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.